Company Overview of ProCertus BioPharm, Inc.
ProCertus BioPharm, Inc., an oncology-based pharmaceutical company, develops therapeutics to protect cancer patients from the side effects of radiotherapy and chemotherapy in the United States. Its products include ProDermaCel that protects cancer patients from chemotherapy- and radiotherapy-induced alopecia; DermX, which prevents radiotherapy-induced dermatitis; and OralX that provides protection against chemotherapy- and radiotherapy- induced oral mucositis. ProCertus BioPharm, Inc. was founded in 1997 and is based in Madison, Wisconsin.
510 Charmany Drive
Suite 175 B
Madison, WI 53719
Founded in 1997
Key Executives for ProCertus BioPharm, Inc.
Similar Private Companies By Industry
|Ted's Tinctures Inc.||United States|
|Dauntless Pharmaceuticals, Inc.||United States|
|Arisaph Pharmaceuticals, Inc.||United States|
|Afferon Corporation||United States|
|OraTech, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact ProCertus BioPharm, Inc., please visit www.procertus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.